Issue Archive
June 2025 | Volume 24 | Issue 6
Editorials
Exploring the Gut Microbiome's Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation
Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa
Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors
An Analysis of Trends of United States Dermatology Clinician Workforce From 2016 to 2023: A Cross-Sectional Study
Considerations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin
Original Articles
Clinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis
Background: Hyperkeratotic psoriatic plaques, characterized by considerable elevation and scaling, present treatment challenges with topical therapy. This post hoc analysis of two phase 3 trials evalu...
Read MoreRapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis
Background: In the ADORING 1 and 2 phase 3 trials, tapinarof cream 1% once daily (QD) demonstrated significant efficacy and was well tolerated in adults and children down to 2 years of age with atopic...
Read MorePractical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection
Acute exacerbations or flares are a key characteristic of atopic dermatitis (AD), often associated with sleep deprivation, as well as experiences of stigmatization, social withdrawal, anxiety, and dep...
Read MoreThiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation
Cutaneous hyperpigmentation, including melasma, solar lentigines, and post-inflammatory hyperpigmentation (PIH), results in a significant impact on patients’ quality of life. Unfortunately, many...
Read MoreA Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Background: Periorificial dermatitis (POD) is a facial skin rash often found in the oral commissures and nasolabial folds, and around the eyes. Treatment options include topical metronidazole and azel...
Read MoreTreatment of Acne-Induced Macular Hyperpigmentation in Fitzpatrick Skin Types V - VI: A Scoping Review
Acne-induced macular hyperpigmentation (AMH) is a common issue among patients with highly melanated skin, particularly those with Fitzpatrick Skin Types (FST) V - VI, which includes nonwhite patients ...
Read MorePDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact
Phosphodiesterase-4 (PDE4) inhibitors are reshaping the treatment landscape for chronic inflammatory skin diseases by offering effective, non-steroidal options for conditions like psoriasis, atopic de...
Read MoreNovel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier
Background: A novel acne cleanser containing 2% Salicylic acid (SA), Polymeric Cleansing Technology (PCT), and a microgel complex, was evaluated for its efficacy in treating mild to moderate acne whil...
Read MoreA Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis
Dandruff is a common skin condition affecting up to half of the world's population. Symptoms include pruritus, inflammation, and flaking. It is thought to be in part due to microbe dysbiosis. This pap...
Read More
Features
The Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market
Benzyl peroxide (BPO) has been an important component of many acne treatment regimens. However, an independent testing laboratory, Valisure, filed a Citizen’s Petition with the US Food and Drug ...
Read MoreOn the Nod: A Scoping Review on Proposed Management Strategies for Erythema Nodosum
Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study
Isotretinoin is used to treat severe nodulocystic acne. Cumulative doses of 120 to 150 mg/kg have been shown to limit adverse events while maximizing efficacy. Also proven safe, doses of 220 mg/kg and...
Read More
Case Reports
Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in neurogenic inflammation and vasodilation, playing a key role in the pathophysiology of both migraines and inflammatory skin conditi...
Read MoreNeed for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used to q...
Read More
Departments
FULL SUPPLEMENT: Acneceuticals maximized therapeutic outcomes in a real-world setting
In this issue:
Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
Acne vulgaris is a common, multifactorial in...
Read More
Supplements
INDIVIDUAL ARTICLE: Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
Background: Acne vulgaris is a common, multifactorial inflammatory skin disease for which there are many pharmacologic and procedural interventions. Recent publications have stressed the importance of...
Read More
